Combining serum albumin and fibrinogen levels, FAR provides a reliable measure of systemic inflammation and is valuable in predicting outcomes in various conditions, including cardiovascular diseases and cancer [11,12]. This evidence concerns the gene ALB and cardiovascular disorder.